Skip to main content

Table 1 Patient demographics

From: Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer

Characteristic

Value

N

49

Age(y)

Median (range)

72(42–89)

T Stage

  T2

7(14%)

  T3

34(70%)

  T4

8(16%)

N Stage

  N0

36(73%)

  N1

13(27%)

M Stage

  M0

40(82%)

  M1

9(18%)

PSA (ng/ml)

Mean (std dev)

16.81 (19.11)

Gleason Score

  6

2(4%)

  7

9(18%)

  8

23(47%)

  9

11(23%)

  10

4(8%)

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us